CHI3L1 and central nervous system cancer: Supporting these findings, the knockdown of CHI3L1/YKL-40 reduced glioma invasion, increased cell death induced by cisplatin, etoposide, and doxorubicin, and decreased cell–matrix adhesion and expression of MMP-2 (25).